|
Diabetes Medication Article
Diabetes Pills
Background Information about Diabetes Pills
Our bodies need glucose as a source of energy for movement, growth, repair, and other functions. When we eat, our bodies break food down into organic compounds, one of which is glucose. But before the cells can use glucose, it must move from the bloodstream into the individual cells. This process requires insulin.
Insulin is produced by the beta cells in the islets of Langerhans in the pancreas. When glucose enters our blood, the pancreas should automatically produce the right amount of insulin to move glucose into our cells. People with type 2 diabetes either produce too little insulin, produce it too late to match the rise in blood glucose, or do not respond correctly to the insulin that is produced. Then glucose builds up in the blood, overflows into the urine, and passes out of the body. This means that the body loses its main source of energy even though the blood contains large amounts of glucose.
Diabetes pills work in one of three ways. They either stimulate the pancreas to release more insulin, increase the body's sensitivity to the insulin that is already present, or slow the breakdown of foods (especially starches) into glucose.
http://www.diabetestestingcenter.com
Diabetes Drug News
Diabetes Drug
BISMARCK, N.D. (AP) — Sen. Byron Dorgan, D-N.D., said he would concentrate during his last months in office on advocating legislation to allow prescription drug imports and repeal a tax benefit for American ...
Read moreDorgan vows new push on drug prices, tax breaks - Crookston Daily Times
Dr. Barry Horowitz once welcomed the drug Avandia as an exciting new tool in his work to control blood sugar in his diabetic patients. That was before a cardiologist at the Cleveland Clinic offered an analysis in 2007 ...
Read moreFDA panel backs diabetes drug Avandia despite heart fears - Palm Beach Interactive
July 29, 2010 -- The popular diabetes drugs Actos and Avandia boost the risk of fracture in older women, according to findings from a new study that echo those of earlier research. For the new study, researcher William H ...
Read moreMore Evidence Links Fractures to Diabetes Drugs - MedicineNet.com
Washington, DC—A nonprofit doctors group filed a lawsuit against the U.S. Food and Drug Administration (FDA) this month, after they failed to notify patients of dietary alternatives to dangerous diabetes ...
Read moreFDA Sued for Failure to Alert Diabetics to Effective Drug Alternatives - Caymanmama.com
WASHINGTON -(Dow Jones)- The Food and Drug Administration warned Abbott Laboratories' ( ABT ) diabetes unit about manufacturing violations involving the company's blood-glucose-monitoring systems. The July 2 letter ...
Read moreFDA Sends Warning Letter To Abbott Diabetes Unit - FOXBusiness
partial tumor shrinkage in a “high-teens” percentage of patients, and a duration of remission of at least four to six months, Coles says. While those measurements are important to the FDA and physicians ...
Read moreOnyx’s Second Drug Candidate Passes Myeloma Study; Company Prepares Dash to FDA - Xconomy
NEW YORK — Shares of obesity drug developer Vivus Inc. slipped Tuesday after an analyst downgraded the stock, saying he thinks it is less likely Vivus's obesity drug Qnexa will be approved. THE SPARK: Brean Murray ...
Read moreVivus falls after analyst says he thinks it's less likely obesity drug Qnexa will be approved - Washington Examiner
Numerate Inc. , a San Bruno company that develops drugs through a combination of computer science and statistics and traditional medicinal chemistry, said it and Intellikine Inc. have ended a cancer drug ...
Read moreNumerate, Intellikine end cancer drug deal - San Francisco Business Journal
The results of the second diabetes drug trial will be known by March 2011, says CEO Engle. Xoma Ltd.’s savior may come in the form of a tiny antibody. After years of turning out monoclonal antibodies for ...
Read moreXoma’s fate rides on diabetes drug trials - Birmingham Business Journal
LONDON (AP) — AstraZeneca PLC said Monday it has reached agreements to pay a modest $198 million to settle a little over half of the U.S. lawsuits that allege its antipsychotic drug Seroquel caused diabetes ...
Read more